Michael Landsittel, CHIEF FINANCIAL OFFICER at Blueprint Medicines Corp (BPMC), sold 5,918 shares at $45.72 ($270K) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Seasonal sale ($270k) by CHIEF FINANCIAL OFFICER — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.48 | 96 | $4K | 1.6% |
| 2 | $45.72 | 2,911 | $133K | 49.2% |
| 3 | $45.72 | 2,911 | $133K | 49.2% |
| Total | $45.70 avg | 5,918 | $270K | 100% |
| Filing → |
| BPMC | SELL | 2024-05-17 | $824K | — | Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |